| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/20/2005 | US20050014207 Monoclonal antibody hPAM4 |
| 01/20/2005 | US20050014199 Mammalian cytokines; receptors; related reagents and methods |
| 01/20/2005 | US20050014191 Transmembrane proteins for use in identifying modulator for treatment of inflammatory, splenic, bone, respiratory and cell proliferative disorders |
| 01/20/2005 | US20050014189 Expression vectors comprising gastrointestinal specific nucleotide sequences for use in detecting, diagnosing, classifying, monitoring, prognosticating, preventing or treating cell proliferative disorders of the gastrointestinal system |
| 01/20/2005 | US20050014187 Novel polypeptide hormone phosphatonin |
| 01/20/2005 | US20050014186 Expression vector comprising nucleotide sequences coding b-aggressive lymphoma (BAL) protein for use as tool in identifying modulators for prevention and treatment of cell proliferative disorders |
| 01/20/2005 | US20050014180 Growth differentiation factor-16 |
| 01/20/2005 | US20050014177 Nucleotide sequences coding high density lipoprotein regulatory molecule for use in diagnosis/prognosis, prevention and treatment of cardiovascular disorders |
| 01/20/2005 | US20050014170 Using single nucleotide polymorphism as diagnostic/prognostic indicator of neuropsychiatric disorders; identifying modulators for treatment of psychological disorders |
| 01/20/2005 | US20050014167 Anterior gradient 2 homolog (AGR2) for use as to in identifying modulator for treatment of asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, vision defects, inflammatory bowel and cell proliferative disorders |
| 01/20/2005 | US20050014152 Drug transporter and use thereof |
| 01/20/2005 | US20050014148 Compositions and methods relating to ovary specific genes and proteins |
| 01/20/2005 | US20050014144 Prediciting strobilurin resistance in fungi via presence of polymorphic sequences in cytochrome b gene; allele specific oligonucleotide hybridization and nucleotide sequence amplification |
| 01/20/2005 | US20050014141 Expression vector comprising nucleotide sequences coding transport protein for use as tool in identifying modulators for treatment of cardiac and nervous system disorders; drug screening |
| 01/20/2005 | US20050014139 Human cyclin I and genes encoding same |
| 01/20/2005 | US20050014138 Using mimetic peptide to generate immunoglobulins for treatment of infections, metabolic and cell proliferative disorders; immunotherapy; peptide therapy |
| 01/20/2005 | US20050014136 Modified HCV NS5 |
| 01/20/2005 | US20050013864 In situ administering; mixture of bone morphogenic protein and ethylene oxide-propylene oxide copolymer |
| 01/20/2005 | US20050013832 Transcutaneous immunization against papillomavirus with papillomavirus virus-like particles |
| 01/20/2005 | US20050013829 Novel growth factor Opa1 and uses thereof |
| 01/20/2005 | US20050013828 Chimeric antigens for eliciting an immune response |
| 01/20/2005 | US20050013827 Novel molecules of the herpesvirus-entry-mediator-related protein family and uses thereof |
| 01/20/2005 | US20050013826 Administering modified protein having disruptive element located in internal region; enhancing ubiquitin proteasome system degradation; effective, long term T cell response |
| 01/20/2005 | US20050013824 Use of highly Immunodominant central nervous system myelin protein; inducing tolerance |
| 01/20/2005 | US20050013817 Human SMAPK3-related gene variants associated with cancers |
| 01/20/2005 | US20050013816 Antibodies or active fragments specific for MORT-1 (Mediator of Receptor Toxicity) protein having amino acid sequence 2; tumors, hiv |
| 01/20/2005 | US20050013815 Prevention and treatment of amyloidogenic disease |
| 01/20/2005 | US20050013814 Methods for treating rheumatoid arthritis using IL-17 antagonists |
| 01/20/2005 | US20050013813 Down Syndrome; and also include Alzheimer's Disease |
| 01/20/2005 | US20050013807 In vitro cultured skin tissue; HIF-1 alpha activity, stable under normoxic conditions; rapid vascularization; burns, wounds |
| 01/20/2005 | US20050013803 Diagnosing and treating cancer cells using mutant viruses |
| 01/20/2005 | US20050013798 IL-1 zeta, IL-1 zeta splice variants and Xrec2 DNAs and polypeptides |
| 01/20/2005 | US20050013797 IL-1 zeta, IL-1 zeta splice variants and Xrec2 DNAs and polypeptides |
| 01/20/2005 | US20050013796 Detection and treatment of breast disease |
| 01/20/2005 | US20050013795 A proteinaceous part having TNF activity and a high molecular polyethylene part bound artificially to the N-terminus of the proteinaceous part, with higher stability; antitumor agents |
| 01/20/2005 | DE10330235A1 Neues Eimeria Gen und Protein sowie deren Verwendung New Eimeria gene and protein and their use |
| 01/20/2005 | DE10328775A1 In vivo-Testsystem zum Nachweis von HIV-Proteaseaktivität In vivo test system for the detection of HIV protease activity |
| 01/20/2005 | CA2536354A1 Atopic dermatitis inducer |
| 01/20/2005 | CA2534090A1 Transgenic mice having a human major histocompatibility complex (mhc) phenotype, experimental uses and applications |
| 01/20/2005 | CA2532535A1 Method of diagnosing disease relating to endometriosis |
| 01/20/2005 | CA2532196A1 Characterization of the earliest stages of the severe acute respiratory syndrome (sars) virus and uses thereof |
| 01/20/2005 | CA2532135A1 Biologically active substance of a vasoactive intestinal peptide for treating interstitial lung infections |
| 01/20/2005 | CA2532024A1 Novel purified polypeptides from staphylococcus aureus |
| 01/20/2005 | CA2531419A1 Method for stabilizing a cryoprecipitate of plasmatic proteins for being subjected to a viral inactivation thermal treatment |
| 01/20/2005 | CA2531222A1 Novel hcv core+1 protein, methods for diagnosis of hcv infections, prophylaxis, and for screening of anti-hcv agents |
| 01/20/2005 | CA2531208A1 Novel immune booster compound comprising an ef adenoviral sequence |
| 01/20/2005 | CA2531161A1 Use of a novel eimeria gene and corresponding protein |
| 01/20/2005 | CA2530994A1 Chloroplast transformation of duckweed |
| 01/20/2005 | CA2530314A1 Appl proteins as rab5 effectors |
| 01/20/2005 | CA2530062A1 Hcv vaccines |
| 01/20/2005 | CA2530029A1 Mutant adeno-associated virus virions and methods of use thereof |
| 01/20/2005 | CA2528120A1 Methods for treating lentivirus infections |
| 01/20/2005 | CA2527102A1 Packaged virus-like particles |
| 01/20/2005 | CA2525091A1 Water-soluble shps as novel alkylating agents |
| 01/20/2005 | CA2524771A1 Non-human animals expressing heterologous complement receptor type 1 (cr1) molecules on erythrocytes and uses therefor |
| 01/19/2005 | EP1498493A1 Method of examining allergic disease |
| 01/19/2005 | EP1498487A1 Novel 35 kd protein |
| 01/19/2005 | EP1498429A2 Rationally designed antibodies |
| 01/19/2005 | EP1498428A1 Antibodies for detecting ecstasy-class analytes |
| 01/19/2005 | EP1498427A1 Immunoglobulins devoid of light chains |
| 01/19/2005 | EP1498425A1 Use of glucagone-like-peptide 1 (GLP-1) derivatives for the preparation of pharmaceutical compositions |
| 01/19/2005 | EP1498424A2 Human nucleic acid sequences from lung tumours |
| 01/19/2005 | EP1498423A1 Regulatory region for Xenopus Lef-1 expression and its use |
| 01/19/2005 | EP1498422A1 C5a Receptor Antagonists |
| 01/19/2005 | EP1498421A1 Gamma-secretase inhibitors |
| 01/19/2005 | EP1498145A1 DECOY FOR TREATING AND/OR PREVENTING Th2 CYTOKINE-ASSOCIATED ALLERGIC DISEASE, GATA3 MUTANT PROTEIN AND MEDICINAL COMPOSITIONS CONTAINING THE SAME |
| 01/19/2005 | EP1498129A1 Use of adenoviruses mutated in the va genes for cancer treatment |
| 01/19/2005 | EP1498027A1 Plant with improved organogenesis and method of constructing the same |
| 01/19/2005 | EP1497660A2 Methods for the selection of compounds useful for the treatment of huntington's disease |
| 01/19/2005 | EP1497659A2 An ephrin-b receptor protein involved in carcinoma |
| 01/19/2005 | EP1497658A2 Protein involved in cancer |
| 01/19/2005 | EP1497649A2 Antibodies specific for mucin polypeptide |
| 01/19/2005 | EP1497646A2 Peptide biomarker and method of identification |
| 01/19/2005 | EP1497634A2 Protein knobs |
| 01/19/2005 | EP1497470A2 Methods of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof |
| 01/19/2005 | EP1497469A2 Assay for evaluation of activity of compounds against hcv using a novel detection system in the hcv replicon |
| 01/19/2005 | EP1497467A2 Oligonucleotides from sequences coding for the surface component of ptlv envelope proteins and uses thereof |
| 01/19/2005 | EP1497460A1 Diagnostic and therapeutic use of ensadin-0138 gene and protein for neurodegenerative diseases |
| 01/19/2005 | EP1497459A2 A device and methods for concentrating prion protein isoforms |
| 01/19/2005 | EP1497454A2 Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer |
| 01/19/2005 | EP1497441A1 Synthetic transfer complex and method for transferring nucleic acids |
| 01/19/2005 | EP1497432A2 Improved bacillus host cell |
| 01/19/2005 | EP1497431A2 Improved bacillus host cell |
| 01/19/2005 | EP1497430A2 Improved bacillus host cell |
| 01/19/2005 | EP1497429A2 Improved bacillus host cell |
| 01/19/2005 | EP1497427A2 Helicokinin-receptor from insects |
| 01/19/2005 | EP1497426A2 Co-stimulatory molecules |
| 01/19/2005 | EP1497425A2 Method of increasing the contractility of a heart, a heart muscle or cells of a heart muscle |
| 01/19/2005 | EP1497423A2 Mcp-1 mutant proteins, antibodies, compositions, methods and uses |
| 01/19/2005 | EP1497422A2 La1 - the genome of a lactobacillus strain |
| 01/19/2005 | EP1497418A2 Phospholipases, nucleic acids encoding them and methods for making and using them |
| 01/19/2005 | EP1497417A2 Epha2 antigen t epitopes |
| 01/19/2005 | EP1497415A2 Cytokine receptor |
| 01/19/2005 | EP1497413A1 Methods for producing immortalised antibodies-secreting cells |
| 01/19/2005 | EP1497412A2 Adenovirus vectors for immunotherapy |
| 01/19/2005 | EP1497334A2 Protein stabilisation using chaperone proteins |
| 01/19/2005 | EP1497330A2 Antagonists of factor viii interaction with low-density lipoprotein receptor-related protein |
| 01/19/2005 | EP1497329A1 Peptides capable of inducing attraction to the axonal growth and their use for treating neurodegenerative diseases |
| 01/19/2005 | EP1497328A2 Regulation of human transient receptor potential channel |
| 01/19/2005 | EP1497327A2 Method for the identification of inhibitors of the binding of are-containing mrna and an hur protein |